- Home
- CADL vs CDRO Comparison
CADL vs CDRO Comparison
Compare CADL & CDRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CADL | CDRO |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | United States | Luxembourg |
| Employees | N/A | 325 |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.4M | 363.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CADL | CDRO |
|---|---|---|
| Price | $5.16 | $8.77 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | ★ $19.00 | $9.00 |
| AVG Volume (30 Days) | ★ 1.0M | 11.5K |
| Earning Date | 05-12-2026 | 02-28-2023 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.62 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,000.00 | N/A |
| Revenue This Year | N/A | $11.31 |
| Revenue Next Year | N/A | $6.75 |
| P/E Ratio | ★ N/A | $305.95 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.34 | $5.18 |
| 52 Week High | $7.24 | $8.91 |
Technical Indicators
Market Signals| Indicator | CADL | CDRO |
|---|---|---|
| Relative Strength Index (RSI) | 54.88 | 73.64 |
| Support Level | $5.15 | $7.73 |
| Resistance Level | $5.25 | N/A |
| Average True Range (ATR) | 0.22 | 0.26 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 94.12 | 97.06 |
Price Performance
Historical ComparisonAbout CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About CDRO Codere Online Luxembourg S.A.
Codere Online Luxembourg SA is an international online casino gaming and online sports betting group focused on providing its customers with a safe and enjoyable online gaming experience. It currently operates in Spain, Mexico, Colombia, and Other countries. where it offers its users the ability to play online casino games and bet on sports events. Online casino offerings include the full portfolio of games typically available in land-based casinos, gaming halls and gambling establishments, such as slot machines, table games, and bingo. Online sports betting involves a user placing a wager on an event at some fixed odds determined by Codere Online. The company derives maximum revenue from Mexico.